Table 6. Pathological type distribution in gene-mutated patients.
Mutated genes | ADC | SCC | |||
---|---|---|---|---|---|
Cases | Rate (%) | Cases | Rate (%) | ||
EGFR | 47 | 95.92 | 2 | 4.08 | |
ALK | 6 | 85.71 | 1 | 14.29 | |
ROS1 | 3 | 75.00 | 1 | 25.00 | |
MET | 3 | 75.00 | 1 | 25.00 | |
ERBB2 (Her2) | 4 | 100.00 | 0 | 0 | |
BRAF | 2 | 100.00 | 0 | 0 | |
KRAS | 6 | 75.00 | 2 | 25.00 |
ADC, adenocarcinoma; SCC, squamous cell carcinoma.